Minister of State for Road Transport and Highways, Shipping and Chemicals & Fertilizers, Shri Mansukh L. Mandaviya, in a written reply to a question in Lok Sabha today, informed that as on 13.12.2017, 3,013 ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Kendras’ are functional in 33 States/UTs of the country.
A State/UT-wise list of 3,013 functional PMBJP Kendras is as below:
S.No. State/UT Kendras
1 Punjab 68
2 Delhi 40
3 Haryana 65
4 Uttar Pradesh 472
5 Uttrakhand 93
6 Madhya Pradesh 86
7 Tripura 24
8 Mizoram 7
9 Andhra Pradesh 125
10 Gujarat 255
11 Karnataka 225
12 Rajasthan 92
13 Maharashtra 200
14 Odisha 65
15 Chandigarh 5
16 Jammu & Kashmir 32
17 Himachal Pradesh 26
18 Jharkhand 46
19 Bihar 84
20 Kerala 315
21 Chattisgarh 193
22 Arunachal Pradesh 24
23 Telangana 70
24 Tamil Nadu 242
25 Assam 49
26 West Bengal 40
27 Nagaland 11
28 Manipur 36
29 Dadar & Nagar Haveli 7
30 Puducherry 10
31 Daman & Diu 3
32 Sikkim 2
33 Meghalaya 1
Total 3013
The situation of shortage of medicines and gap in the distribution of the medicines from Central Ware House (CWH) of Bureau of Pharma PSUs of India (BPPI) (the implementing agency of PMBJP) to PMBJP Kendras has been improved and as on 13.12.2017, the Minister informed.
647 medicines and 129 surgical & consumables are available in CWH for sale covering 23 major therapeutic groups. BPPI has also initiated end to end supply solution to supply the medicines and other PMBJP products directly to PMBJP Kendras from CWH to reduce the time and cost. This will improve the supply position further, Shri Mandaviya informed.
Further, the Minister stated that to improve the distribution system of medicines to PMBJP Kendras/shops, Government has appointed 55 Distributors, 8 Carrying & Forwarding (C&F) Agents and 1 Central Ware House (CWH). To increase the profitability of PMBJP Kendra owners, trade margins have been revised from 16% to 20% for retailers under the scheme.
Incentives are provided to PMBJP Kendras run by private entrepreneurs/ pharmacists/ NGOs/ Charitable organizations that are linked with BPPI’s software will get incentive upto Rs. 2.5 lakhs. This will be given @ 15% of monthly sales subject to a ceiling of Rs. 10,000/ per month and in case of north eastern states, naxal affected areas and tribal areas, ceiling of Rs. 15,000/- per month upto a total limit of Rs. 2.5 lakhs. Awareness drives have been started through print media, television advertisements, FM radio, outdoor publicity, social media, etc., informed Shri Mandaviya.
Prescribing Generics Drugs
Ministry of Health & Family Welfare has published a draft notification for public comments vide GSR 302 (E) dated 30.03.2017 for amendment of Rule 96 of the Drugs & Cosmetics Rules, 1945 to provide that the proper name of the drugs shall be printed in a conspicuous manner which shall be in the same font but at least two font size larger than the brand name or the trade name, if any.
Medical Council of India (MCI) has notified an amendment in Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 vide notification dated 21.09.2016, which stipulates that “Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs”. MCI has further issued a circular on 21.04.2017 vide which all the Registered Medical Practitioners under the Indian Medical Council (IMC) Act have been directed to comply with the aforesaid provisions.
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha.